跳至主要内容
临床试验/JPRN-UMIN000020848
JPRN-UMIN000020848已完成2 期

A phase II study on the carbon-ion radiotherapy for T1c-T3N0M0 localized prostate cancer - Carbon-ion radiotherapy for localized prostate cancer (iROCK-1501PR)

Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization0 个研究点目标入组 145 人开始时间: 2016年2月3日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
145

研究概览

简要总结

This study confirmed safety and efficacy comparable to those reported from prior facilities.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1) Patient with past history of radiotherapy for the targeted lesion 2) Patient with castration-resistant prostate cancer 3) Patient with active double cancer 4) Patients with active and intractable infection in the targeted lesion. 5) Patient with metal devices in the lesion 6) Other medical or psychological condition which is unsuitable for carbon-ion therapy

研究者

发起方
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization

相似试验